Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs

Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs

Abstract Background The aim of this study was to investigate the anti-obesity effects of DWP16001, a sodium-glucose cotransporter-2 (SGLT2 inhibitor), in naturally obese dogs. A total of 20 dogs were divided into four equal groups: one obese control (OC group), and three treated groups; DWP0.2 group...

Full description

Bibliographic Details
Main Authors: Beomseok Rhee, Rahman Md Mahbubur, Changfan Jin, Ji-Soo Choi, Hyun-Woo Lim, Wan Huh, Joon Seok Park, Jumi Han, Sokho Kim, Youngwon Lee, Jinho Park
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Veterinary Research
Subjects:
Dogs
DWP16001
Obesity
SGLT2 inhibitor
Online Access:https://doi.org/10.1186/s12917-022-03324-2

Internet

https://doi.org/10.1186/s12917-022-03324-2

Similar Items